INCY
Incyte Corporation · Healthcare
President, Global Head of R&D Pablo J Cagnoni sold $1.3M of Incyte Corporation
Sold$1,305,422
$122.69Price
10,640Shares
−5%Stake
What INCY did after the filing
- The stock from Mon, Aug 10 open, $120.56
- +3.4%
- S&P 500, same days
- −0.6%
Measured over 30 trading days, to the Sep 23 close.
Traded Wed, Aug 5. Filed Fri, Aug 7, 4:02 PM ET, after the close. Returns use the Aug 10 open and the Sep 23 close. Not investment advice.